ClinicalTrials.Veeva
Menu

Find clinical trials for Pancreatic Cancer in Houston, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Adenocarcinoma
Cancer
Carcinoma
Colorectal Cancer
Lung Cancer
Non-Small-Cell Lung Carcinoma
Squamous Cell Carcinoma of Head and Neck

Pancreatic Cancer trials near Houston, TX, USA:

LOAd703 Oncolytic Virus Therapy for Pancreatic Cancer

The purpose of this study is to see if LOAd703 (an oncolytic adenovirus) can be safely given to patients with pancreatic cancer. Th...

Enrolling
Pancreatic Cancer
Drug: nab-paclitaxel
Drug: gemcitabine

Phase 1, Phase 2

Lokon Pharma

Houston, Texas, United States and 1 other location

This research study is studying a combination of interventions as a possible treatment for pancreatic tumor.The interventions involved in th...

Active, not recruiting
Pancreatic Cancer
Drug: Nivolumab
Drug: FOLFIRINOX

Phase 2

Mass General Brigham
Mass General Brigham

Houston, Texas, United States and 9 other locations

with either gemcitabine plus nab-paclitaxel (G/NP) or FOLFIRINOX in the treatment of participants with locally advanced, unresectable pancreatic...

Active, not recruiting
Pancreatic Cancer Non-resectable
Drug: Pamrevlumab + Gemcitabine + Nab-paclitaxel or Pamrevlumab + FOLFIRINOX
Drug: Placebo + Gemcitabine + Nab-paclitaxel or Placebo + FOLFIRINOX

Phase 3

FibroGen
FibroGen

Houston, Texas, United States and 89 other locations

To learn if piflufolastat F18 can be used in imaging scans for patients with breast cancer, HCC, or pancreatic cancer...

Enrolling
Breast Cancer
Pancreatic Cancer
Drug: Piflufolastat F18

Phase 1

M.D. Anderson Cancer Center
M.D. Anderson Cancer Center

Houston, Texas, United States

To learn if the investigational study drug, adagrasib (also called MRTX849), can help to control pancreatic cancer that has a KRAS ...

Enrolling
Metastatic Pancreatic Cancer
Drug: MRTX849

Phase 1

M.D. Anderson Cancer Center
M.D. Anderson Cancer Center

Houston, Texas, United States

open label, multi-center, clinical study of Chimeric Antigen Receptor T Cells (CAR-T) targeting claudin18.2 in patients with advanced gastric, pancreatic...

Active, not recruiting
Gastric Cancer
Pancreatic Cancer
Biological: CT041

Phase 1, Phase 2

CARsgen Therapeutics

Houston, Texas, United States and 15 other locations

A Phase 1/1b dose finding study to determine the OBD(s) and RP2D(s) of BMF-219, a covalent menin inhibitor small molecule, in subjects with KRAS muta...

Enrolling
Stage III Non-small Cell Lung Cancer
Stage III Pancreatic Cancer
Drug: BMF-219

Phase 1

Biomea Fusion

Houston, Texas, United States and 22 other locations

Study of NGM120 in subjects with advanced solid tumors and and pancreatic cancer (Part 1 and 2) and metastatic castration resistant...

Active, not recruiting
Bladder Cancer
Esophageal Cancer
Biological: NGM120
Other: Placebo

Phase 1, Phase 2

NGM Biopharmaceuticals

Houston, Texas, United States and 21 other locations

This phase II trial studies how well danvatirsen and durvalumab work in treating patients with pancreatic cancer, non-small cell lu...

Active, not recruiting
Stage IVC Colorectal Cancer AJCC v8
Stage IIIA Lung Cancer AJCC v8
Biological: Durvalumab
Drug: Danvatirsen

Phase 2

M.D. Anderson Cancer Center
M.D. Anderson Cancer Center

Houston, Texas, United States

and clinical activity of AB680 in combination with Zimberelimab (AB122), nab-paclitaxel and gemcitabine in participants with advanced pancreatic...

Enrolling
Advanced Pancreatic Cancer
Drug: Zimberelimab
Drug: Gemcitabine

Phase 1

Arcus Biosciences
Arcus Biosciences

Houston, Texas, United States and 17 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems